Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Genes Nutr ; 15(1): 17, 2020 Sep 23.
Artigo em Inglês | MEDLINE | ID: mdl-32967625

RESUMO

Grapes and berries are two types of widely consumed fruits characterized by a high content in different phytochemicals. However, their accurate dietary assessment is particularly arduous, because of the already wide recognized bias associated with self-reporting methods, combined with the large range of species and cultivars and the fact that these fruits are popularly consumed not only in fresh and frozen forms but also as processed and derived products, including dried and canned fruits, beverages, jams, and jellies. Reporting precise type and/or quantity of grape and berries in FFQ or diaries can obviously be affected by errors. Recently, biomarkers of food intake (BFIs) rose as a promising tool to provide accurate information indicating consumption of certain food items. Protocols for performing systematic reviews in this field, as well as for assessing the validity of candidate BFIs have been developed within the Food Biomarker Alliance (FoodBAll) Project. This paper aims to evaluate the putative BIFs for blueberries, strawberries, raspberries, blackberries, cranberries, blackcurrant, and grapes. Candidate BFIs for grapes were resveratrol metabolites and tartaric acid. The metabolites considered as putative BFI for berries consumption were mostly anthocyanins derivatives together with several metabolites of ellagitannins and some aroma compounds. However, identification of BFIs for single berry types encountered more difficulties. In the absence of highly specific metabolites reported to date, we suggested some multi-metabolite panels that may be further investigated as putative biomarkers for some berry fruits.

2.
Diabetes Metab ; 45(2): 167-174, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-29555466

RESUMO

AIM: To characterize the urinary metabolomic fingerprint and multi-metabolite signature associated with type 2 diabetes (T2D), and to classify the population into metabotypes related to T2D. METHODS: A metabolomics analysis using the 1H-NMR-based, non-targeted metabolomic approach was conducted to determine the urinary metabolomic fingerprint of T2D compared with non-T2D participants in the PREDIMED trial. The discriminant metabolite fingerprint was subjected to logistic regression analysis and ROC analyses to establish and to assess the multi-metabolite signature of T2D prevalence, respectively. Metabotypes associated with T2D were identified using the k-means algorithm. RESULTS: A total of 33 metabolites were significantly different (P<0.05) between T2D and non-T2D participants. The multi-metabolite signature of T2D comprised high levels of methylsuccinate, alanine, dimethylglycine and guanidoacetate, and reduced levels of glutamine, methylguanidine, 3-hydroxymandelate and hippurate, and had a 96.4% AUC, which was higher than the metabolites on their own and glucose. Amino-acid and carbohydrate metabolism were the main metabolic alterations in T2D, and various metabotypes were identified in the studied population. Among T2D participants, those with a metabotype of higher levels of phenylalanine, phenylacetylglutamine, p-cresol and acetoacetate had significantly higher levels of plasma glucose. CONCLUSION: The multi-metabolite signature of T2D highlights the altered metabolic fingerprint associated mainly with amino-acid, carbohydrate and microbiota metabolism. Metabotypes identified in this patient population could be related to higher risk of long-term cardiovascular events and therefore require further studies. Metabolomics is a useful tool for elucidating the metabolic complexity and interindividual variation in T2D towards the development of stratified precision nutrition and medicine. Trial registration at www.controlled-trials.com: ISRCTN35739639.


Assuntos
Biomarcadores , Diabetes Mellitus Tipo 2/classificação , Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/metabolismo , Metaboloma/fisiologia , Metabolômica/métodos , Idoso , Biomarcadores/análise , Biomarcadores/metabolismo , Doenças Cardiovasculares/prevenção & controle , Estudos Transversais , Diabetes Mellitus Tipo 2/epidemiologia , Angiopatias Diabéticas/prevenção & controle , Dieta Mediterrânea , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Urinálise/métodos
3.
Curr Pharm Biotechnol ; 13(5): 624-31, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22122477

RESUMO

Cardiovascular disease (CVD) mortality rates are lower in Asian countries where dietary patterns are very different from Western diet. A number of studies have linked these lower rates to the inclusion of soy products as a staple food in those countries. Soy is the richest dietary source of isoflavones, a type of phytoestrogen associated with many potentially beneficial effects. Isoflavone-containing soy protein consumption has been linked to reduced levels of LDL cholesterol in hypercholesterolemic patients. This effect is increased with the concomitant administration of isoflavones, and seems to be also complemented by the isoflavone capacity to restore the endothelial function in patients with weak and moderated endothelial dysfunction. The effects are variable depending on individuals� � � metabolism and in particular to their ability to convert daidzein to equol that seems to be restricted to approximately 1/3 of the population. Equol production has been indeed linked to a decreased arterial stiffness and antiatherosclerotic effects via NO production. Because the relevance of isoflavones consumption on the modulation of cardiovascular risk still remains unclear, this paper aims to review the existing knowledge on the biological activity of the isoflavones on the human cardiovascular system from an epidemiological, clinical and -omics point of view.


Assuntos
Doenças Cardiovasculares/epidemiologia , Glycine max , Isoflavonas/administração & dosagem , Proteínas de Soja/administração & dosagem , Doenças Cardiovasculares/prevenção & controle , Humanos
4.
J Ethnopharmacol ; 102(3): 344-50, 2005 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-16084679

RESUMO

In Unani system of medicine, drugs consist of complex formulae with more than three components, for which, literature analysing these mixtures as they are sold in the market is scarce. In this paper, the main botanical components of the herbal tea known as "Zahraa" in Damascus, which contains between 6 and 14 species components is elucidated: Alcea damascena (Mout.) Mout. (Malvaceae), Aloysia triphylla (L'Herit.) Britt. (Malvaceae), Astragalus cf. amalecitanus Boiss., Cercis siliquastrum L. subsp. hebecarpa (Bornm.) Yalt. and subsp. siliquastrum. (Leguminosae), Colutea cilicica Boiss. et Bal. in Boiss. (Leguminosae), Crataegus aronia (L.) Bosc. ex DC. (Rosaceae), Cytisopsis pseudocytisus (Boiss.) Fertig. (Leguminosae), Eleagnus angustifolia L. (Eleagnaceae), Equisetum telmateia Ehrh. (Equisetaceae), Helichrysum stoechas (L.) Moench. subsp. barrelieri (Ten.) Nyman. (Compositae), Matricaria recutita L. (Compositae), Mentha longifolia L. subsp. noeana (Boiss. ex. Briq.) Briq. (Labiatae), Mentha spicata L. subsp. condensata (Briq.) Greuter and Burdet (Labiatae), Micromeria myrtifolia Boiss. and Hohen. in Boiss. (Labiatae), Paronychia argentea Lam. (Caryophyllaceae), Phlomis syriaca Boiss. (Labiatae), Rosa damascena Mill. (Rosaceae), Salvia fruticosa Mill. (Labiatae), Sambucus nigra L. (Caprifoliaceae), Spartium junceum L. (Leguminosae), Zea mays L. (Gramineae).


Assuntos
Bebidas/análise , Medicina Tradicional , Plantas Medicinais/química , Síria
5.
J Physiol Pharmacol ; 56 Suppl 1: 97-114, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15800388

RESUMO

We studied medicinal and food plant species, recording an extraordinary number of species and uses in Castilla-La Mancha, Murcia and Valencia in Spain. Focusing on two demographically distinct regions - Castilla-La Mancha and Lower Segura Valley. A high proportion of the flora (20 to 30 %) is known for its medicinal properties, and, interestingly, a high number of medicinal-food plants (5 to 7 %) is recorded. The concept of "Local Food" involves the whole repertory of species that characterises the local diet (incl. local cultivars and non-cultivated gathered food plants). The number of food plant species varies between 15 and 25 % of the vascular flora, and for the gathered food plants (GFP) this decreases to a 3 to 8 %. Those GFP that are also used for medicinal purposes are only 2 to 4 % of the total vascular flora. The relevant plant families are very similar in relative numbers along the different areas: Compositae, Rosaceae and Umbelliferae, followed of Boraginaceae, Liliaceae, Cruciferae, and Caryophyllaceae. Chenopodiaceae, Polygonaceae and Gramineae are less uniformly represented or in lesser numbers. The high species diversity does not imply a general dietary relevance of this particular plant family. For instance Caryophyllaceae with a relatively low number of species comprises the "collejas" (Silene vulgaris) that have shown to be the more widely consumed species. Information regarding 145 species has been recorded. Among the Gathered Food Plant Species 81 are used in medicine, in double proportion than the cultivated food plants. 61 are orally administered, in the same form as food.


Assuntos
Dieta Mediterrânea/etnologia , Plantas Comestíveis , Plantas Medicinais , Etnobotânica , Feminino , Humanos , Masculino , Mortalidade , Espanha
6.
J Mass Spectrom ; 39(3): 312-21, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15039939

RESUMO

The LC/UV-DAD/ESI-MSn negative fragmentation mode of 23 O-glycosylated flavonoids with two, three, four and five hexoses was studied. The results show that it is possible to differentiate the (1-->2) and (1-->6) interglucosidic linkages and also to discern between the flavonoid isomers with two glucoses (sophorosides, gentiobiosides and X,Y-diglucosides), three glucoses (sophorotriosides and X-sophoroside-Y-glucoside) and four glucoses (X-sophorotriosides-Y-glucoside and X-sophoroside-Y-sophoroside). In the characterization of the (1-->2) and (1-->6) interglycosidic linkages, the Y1- (-162 u) and Z1- (-180 u) ions play a relevant role. In the first case ions with high relative abundance (13-79%) are found, whereas in the other cases they are in very low abundance or absent. X,Y-di-O-glucoside flavonoids can be differentiated from the O-diglucoside flavonoids by the presence of Y1- (base peak) and Y0- (approximately 30%) ions and the absence of Z1- ions. Regarding flavonoids glycosylated with three glucoses, X-sophoroside-Y-glucoside flavonoids show the Y7(0-) (-162 u) ion as the only peak in MS2 events whereas in sophorotrioside flavonoids various ions due to intermediate fragmentations are observed. These ions are characteristic of a (1-->2) interglucosidic linkage. In MS2 experiments on flavonoids with four glucoses (X-sophorotrioside-Y-glucoside and X-sophoroside-Y-sophoroside), the base peak indicated the total loss of the sugar moieties in position 7. In addition, the characterization of the type of interglycosidic linkage in flavonoids glycosylated with five sugars can be achieved. On the other hand, in tetra- and pentaglycosylated flavonoids, the ions that characterize the (1-->2) interglucosidic linkage formed by intermediate fragmentation of the oligosacharide residues (sophorosides and sophorotriosides) are found in much higher relative abundance in MS3 than in MS2 experiments, where they are almost not detected.


Assuntos
Cromatografia Líquida/métodos , Flavonoides/análise , Espectrometria de Massas/métodos , Proteínas de Plantas/análise , Flavonoides/química , Flavonoides/metabolismo , Glucose/metabolismo , Glicosilação , Quempferóis/análise , Quempferóis/química , Quempferóis/metabolismo , Proteínas de Plantas/química , Proteínas de Plantas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...